Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1998 2
1999 3
2000 3
2001 2
2002 3
2003 3
2004 8
2005 4
2006 4
2007 4
2008 2
2009 6
2010 1
2011 2
2012 4
2013 2
2014 11
2015 10
2016 12
2017 14
2018 5
2019 6
2020 10
2021 10
2022 6
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Results by year

Filters applied: . Clear all
Page 1
Neuroendocrine neoplasms of rectum: A management update.
Bertani E, Ravizza D, Milione M, Massironi S, Grana CM, Zerini D, Piccioli AN, Spinoglio G, Fazio N. Bertani E, et al. Among authors: grana cm. Cancer Treat Rev. 2018 May;66:45-55. doi: 10.1016/j.ctrv.2018.04.003. Epub 2018 Apr 6. Cancer Treat Rev. 2018. PMID: 29684743 Review.
Applying the WHO 2010 grading system to whole NENs originating in the gastroenteropancreatic system, R-NENs are classified as Well-Differentiated Neuroendocrine Tumors (WD-NET), which contain NET G1 and NET G2, and Poorly-Differentiated Carcinomas (PD-NEC) enclosing only G3 ne …
Applying the WHO 2010 grading system to whole NENs originating in the gastroenteropancreatic system, R-NENs are classified as Well-Different …
Peptide Receptor Radionuclide Therapy (PRRT): Innovations and Improvements.
Merola E, Grana CM. Merola E, et al. Among authors: grana cm. Cancers (Basel). 2023 May 30;15(11):2975. doi: 10.3390/cancers15112975. Cancers (Basel). 2023. PMID: 37296936 Free PMC article. Review.
Neuroendocrine neoplasms (NENs) are tumors originating from neuroendocrine cells distributed throughout the human body. With an increasing incidence over the past few decades, they represent a highly heterogeneous group of neoplasms, mostly expressing somatostatin r …
Neuroendocrine neoplasms (NENs) are tumors originating from neuroendocrine cells distributed throughout the human body. With an incre …
Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective.
Cremonesi M, Chiesa C, Strigari L, Ferrari M, Botta F, Guerriero F, De Cicco C, Bonomo G, Orsi F, Bodei L, Di Dia A, Grana CM, Orecchia R. Cremonesi M, et al. Among authors: grana cm. Front Oncol. 2014 Aug 19;4:210. doi: 10.3389/fonc.2014.00210. eCollection 2014. Front Oncol. 2014. PMID: 25191640 Free PMC article. Review.
Multicentric breast cancer with heterogeneous histopathology: a multidisciplinary review.
Corso G, Magnoni F, Provenzano E, Girardi A, Iorfida M, De Scalzi AM, Invento A, Colleoni M, Cassano E, Trentin C, Gullo RL, Pravettoni G, Gilardi L, Grana CM, Intra M, Galimberti V, Veronesi P, De Lorenzi F, Leonardi MC. Corso G, et al. Among authors: grana cm. Future Oncol. 2020 Mar;16(8):395-412. doi: 10.2217/fon-2019-0540. Epub 2020 Feb 6. Future Oncol. 2020. PMID: 32026709 Review.
Tailored Molecular Imaging of Pheochromocytoma and Paraganglioma: Which Tracer and When.
Di Stasio GD, Cuccurullo V, Cascini GL, Grana CM. Di Stasio GD, et al. Among authors: grana cm. Neuroendocrinology. 2022;112(10):927-940. doi: 10.1159/000522089. Epub 2022 Jan 20. Neuroendocrinology. 2022. PMID: 35051937 Free article. Review.
Pheochromocytoma (PCC) and paraganglioma (PGL) are rare neoplasms that fall within the category of neuroendocrine tumors. In the last decade, their diagnostic algorithm has been modified to include the evaluation of molecular pathways, genotype, and biochemical phenotype, …
Pheochromocytoma (PCC) and paraganglioma (PGL) are rare neoplasms that fall within the category of neuroendocrine tumors. In the last …
Peptide receptor therapies in neuroendocrine tumors.
Bodei L, Ferone D, Grana CM, Cremonesi M, Signore A, Dierckx RA, Paganelli G. Bodei L, et al. Among authors: grana cm. J Endocrinol Invest. 2009 Apr;32(4):360-9. doi: 10.1007/BF03345728. J Endocrinol Invest. 2009. PMID: 19636207 Review.
Yttrium-labelled peptides for therapy of NET.
Bodei L, Cremonesi M, Grana CM, Chinol M, Baio SM, Severi S, Paganelli G. Bodei L, et al. Among authors: grana cm. Eur J Nucl Med Mol Imaging. 2012 Feb;39 Suppl 1:S93-102. doi: 10.1007/s00259-011-2002-y. Eur J Nucl Med Mol Imaging. 2012. PMID: 22388625 Review.
Predictive Markers of Response to Everolimus and Sunitinib in Neuroendocrine Tumors.
Martins D, Spada F, Lambrescu I, Rubino M, Cella C, Gibelli B, Grana C, Ribero D, Bertani E, Ravizza D, Bonomo G, Funicelli L, Pisa E, Zerini D, Fazio N; IEO ENETS Center of Excellence for GEP NETs. Martins D, et al. Among authors: grana c. Target Oncol. 2017 Oct;12(5):611-622. doi: 10.1007/s11523-017-0506-5. Target Oncol. 2017. PMID: 28634872 Review.
Interim 18F-FDG-PET/CT during chemo-radiotherapy in the management of oesophageal cancer patients. A systematic review.
Cremonesi M, Garibaldi C, Timmerman R, Ferrari M, Ronchi S, Grana CM, Travaini L, Gilardi L, Starzyńska A, Ciardo D, Orecchia R, Jereczek-Fossa BA, Leonardi MC. Cremonesi M, et al. Among authors: grana cm. Radiother Oncol. 2017 Nov;125(2):200-212. doi: 10.1016/j.radonc.2017.09.022. Epub 2017 Oct 10. Radiother Oncol. 2017. PMID: 29029833 Review.
125 results